Lenvatinib Rechallenge After Ramucirumab Treatment Failure for Hepatocellular Carcinoma. Komatsu S, Yano Y, Kido M, Kuramitsu K, et al. Anticancer Res 2021;41:4555-4562.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Komatsu S, Yano Y, Kido M, Kuramitsu K, et al. Lenvatinib Rechallenge After Ramucirumab Treatment Failure for Hepatocellular Carcinoma. Anticancer Res 2021;41:4555-4562.
PMID: 34475083